Company Profile
Updated: 17-SEP-09Symbollon Pharmaceuticals Inc.
Public Company, Headquarters Location
37 Loring Dr., Framingham, MA 01702-8768, United States
(508)620-7676, (508)620-7111 fax, http://www.symbollon.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Biochemical research and development of iodine based pharmaceutical agents.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1469 words; ...2007.) o Javelin Pharmaceuticals Inc., of Cambridge, Mass...o Lorus Therapeutics Inc., of Toronto, said...schedule. o Myriad Genetics Inc., of Salt Lake City...protein inhibitor. o Symbollon Pharmaceuticals Inc...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1420 words; ...end of the year. Barr Pharmaceuticals Inc., of Woodcliff Lake...Alnylam Pharmaceuticals Inc. and South San Francisco-based Hana Biosciences Inc. will transfer to Tekmira...search and match process. Symbollon Pharmaceuticals Inc...
Stock Profiler.US: Stock Watch: SYMBA, CICN, EWRC.
M2 Presswire; 7/8/2009; 1279 words; ...About Symbollon Pharmaceuticals, Inc. Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) is a specialty pharmaceutical company focused...information about Symbollon, please visit...Cicero Inc. closed at $0...
Hub Health: Boston Boston Cluster Challenged to Remain Competitive.(Company overview)
BIOWORLD Today; 5/14/2009; 1817 words; ...Cambridge-based Alnara Pharmaceuticals Inc., Worcester-based...Waltham Technologies Inc. Historically, Massachusetts...Marlborough-based Sepracor Inc. said it planned to...bankruptcy this year. Symbollon Pharmaceuticals Inc...
Symbollon Pharmaceuticals Announces 2008 Year-End Results.(Financial report)
Internet Wire; 3/31/2009; 1468 words; ...strategic alternative, we will be forced to cease operations." About Symbollon Pharmaceuticals, Inc. Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) is a specialty pharmaceutical company focused on the development and commercialization of proprietary...
Recent News Articles
- Symbollon Pharmaceuticals Inc-Financial Company Report.
M2 Presswire - February 22, 2009 - (OTCBB:SYMBA) Symbollon Pharmaceuticals, Inc. just released some important news.
M2 Presswire - September 19, 2008 - Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease.
PR Newswire - September 24, 2007 - Symbollon Pharmaceuticals Inc. Against the Global Market.
M2 Presswire - June 20, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning